Cutaneous Adverse Reactions Associated with Monoclonal Antibodies Treatment in Multiple Sclerosis: Case Reports and Short Literature Review

Cutaneous Adverse Reactions Associated with Monoclonal Antibodies Treatment in Multiple Sclerosis: Case Reports and Short Literature Review

Background and aims. Multiple sclerosis is a disease of the central nervous system, whose treatment often involves the use of monoclonal antibodies. This can lead to a series of complications that the clinician should pay attention to and accordingly adjust the therapy. We aim to emphasize real-life...

Full description

Bibliographic Details
Main Authors: Carmen Adella Sirbu, Raluca Ivan, Titus Mihai Vasile, Lucian George Eftimie, Daniel Octavian Costache
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Journal of Clinical Medicine
Subjects:
multiple sclerosis
monoclonal antibodies
natalizumab
ocrelizumab
adverse skin reactions
Online Access:https://www.mdpi.com/2077-0383/11/13/3702

Similar Items

Similar Items